<SEC-DOCUMENT>0001176256-15-000202-index.html : 20150515
<SEC-HEADER>0001176256-15-000202.hdr.sgml : 20150515
<ACCEPTANCE-DATETIME>20150515171916
ACCESSION NUMBER:		0001176256-15-000202
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20150331
FILED AS OF DATE:		20150515
DATE AS OF CHANGE:		20150515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NYMOX PHARMACEUTICAL CORP
		CENTRAL INDEX KEY:			0001018735
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12033
		FILM NUMBER:		15870952

	BUSINESS ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
		BUSINESS PHONE:		1-800-936-9669

	MAIL ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>nymoxPharma6kq1fs.htm
<DESCRIPTION>REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED MARCH 31, 2015
<TEXT>
Document 1 - file: nymoxPharma6kq1fs.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>QUARTERLY REPORT FOR THE QUARTER ENDED MARCH 31, 2015
<TEXT>
Document 2 - file: exhibit99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit99-2.htm
<DESCRIPTION>CEO CERTIFICATIONS
<TEXT>
Document 3 - file: exhibit99-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit99-3.htm
<DESCRIPTION>CFO CERTIFICATIONS
<TEXT>
Document 4 - file: exhibit99-3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>exhibit99-1x1x1.jpg
<TEXT>
Document 5 - file: exhibit99-1x1x1.jpg

</DOCUMENT>
</SEC-DOCUMENT>